Tag: clinical trial

INDUSTRY AND GOVERNMENT LEADERS OUTLINE POTENTIAL FOR SOCIAL MEDIA TO ACCELERATE PRO DEVELOPMENT

Raritan, NJ, USA – A collaboration designed to open dialogue between industry and government leaders has found “great potential” for social media to support content validity of patient-reported outcomes (PRO) instruments, and outlined how the use of social media can

Posted in Commentary, Value in Health Tagged with: , , , , , ,

Improving Clinical Trial Participation Through Patient-Centered Trial Design

Baltimore, MD, USA – Many people are reluctant to participate in clinical trials.  This reluctance stems from the perception of risk while not seeing any clear benefit to participation.  The exception is when an individual has a condition for which there

Posted in Policy Perspectives, Value in Health Tagged with: , , , , ,

Issues And Challenges When Pharma Works With Regulators & HTA Agencies

Canberra, Australia – The pivotal phase III clinical trials for new medicines are designed to support their registration, yet they are also used to support their reimbursement and pricing. The clinical evidence needs of HTA agencies (payers) are often different than

Posted in Health Policy Analyses, Value in Health Tagged with: , , ,

Innovative Methods Can Identify Differential Responders To Treatment

Manchester, UK – In the article, “Innovative Data Analysis for Demonstrating Product Value: Analysis of Heterogeneity in Treatment Response in Clinical Trials,” published in Vol. 19 Issue 1 of ISPOR CONNECTIONS, Dr. Donald E. Stull and Katherine Houghton assessed an example of

Posted in ISPOR CONNECTIONS, Value & Outcomes Spotlight Tagged with: , , ,